Description
ELECTROLITOS ORALES. POLVO PARA SOLUCION ORAL. CADA SOBRE CONTIENE: GLUCOSA 20.0 G. CLORURO DE POTASIO 1.5 G. CLORURO DE SODIO 3.5 G. CITRATO TRISODICO DIHIIDRATADO 2.9 G. SOBRE CON 27.9 G.
IMSS product code
010.000.3623.02
Each circle represents one of the 166 purchases of ELECTROLITOS ORALES made by the IMSS between 2009 and 2012.
| SUPPLIER | PURCHASES | OVERCOST IN MXN | OVERCOST IN % | LOST QUANTITY | TIME PERIOD |
|---|---|---|---|---|---|
| DIBITER, S.A. DE C.V. | 37 | 283,854.1 MXN | 7.19 % | 133,676.1 | 2009 - 2012 |
| DISTRIBUIDORA DE FARMACOS Y FRAGANCIAS, SA DE CV | 22 | 111,775.1 MXN | 31.4 % | 51,744.1 | 2009 - 2012 |
| PROTEIN, S. A. DE C. V. | 15 | 44,346.8 MXN | 9.13 % | 20,093.9 | 2010 - 2012 |
| MESALUD, S. A. DE C. V. | 14 | 84,977.5 MXN | 7.91 % | 38,563.2 | 2009 - 2012 |
| BIOMA FARMACEUTICA, S.A. DE C.V. | 9 | 32,909.8 MXN | 82 % | 14,914.9 | 2010 - 2012 |
| FARMACEUTICO EMPRESARIAL MARTINEZ S.A DE C.V. | 7 | 316,314.5 MXN | 62.2 % | 146,266 | 2011 - 2012 |
| MEDSUR S DE R L | 7 | 3,691.1 MXN | 81.8 % | 1,674.3 | 2011 - 2012 |
| GONZALEZ LOBATO FRANCISCA SARA | 5 | 139.7 MXN | 242.4 % | 63.3 | 2012 - 2012 |
| S&M DISTRIBUTION, S. DE R.L. DE C.V. | 5 | 22,452.9 MXN | 60.7 % | 10,397.7 | 2010 - 2011 |
| COMERCIALIZADORA PHARMACEUTICA COMPHARMA SA DE CV | 4 | 15,746.2 MXN | 10.2 % | 7,309.4 | 2011 - 2011 |
| ARTICULOS MEDICOSY HOSPITALARIOS, S.A DE.C.V | 3 | 33,898.1 MXN | 25.5 % | 15,522.9 | 2011 - 2012 |
| DOMINGUEZ BRAVO ROSIO | 3 | 191.9 MXN | 579.4 % | 86.9 | 2012 - 2012 |
| HISA FARMACEUTICA, S. A. DE C. V. | 3 | 13,521 MXN | 16.2 % | 6,123.7 | 2012 - 2012 |
| NOVAG INFANCIA, S. A. DE C. V. | 3 | 4,364.5 MXN | 2.78 % | 1,976.7 | 2012 - 2012 |
| OCHOA BRACAMONTES JESUS RAFAEL | 3 | 390.2 MXN | 34.3 % | 198.6 | 2009 - 2009 |
| PHARMAINDUSTRIAS DE SINALOA, S. DE R. L. | 2 | 111,726.3 MXN | 47.2 % | 50,601.6 | 2012 - 2012 |
| PROMELAB COMERCIALIZADORA, S.A. DE C.V. | 2 | 115,761.6 MXN | 129 % | 58,910.6 | 2009 - 2009 |
| SERVICIOS EMPRESARIALES DE DIST. MEDICAS, S DE RL | 2 | 3,505.5 MXN | 194.4 % | 1,587.7 | 2012 - 2012 |
| ARSENAL MEDICO, S.A. DE C.V. | 1 | 15,989.7 MXN | 51.7 % | 7,241.8 | 2012 - 2012 |
| COMERCIALIZADORA GAYDI, S.A. DE C.V. | 1 | 1,151.8 MXN | 103.6 % | 586.1 | 2009 - 2009 |
| COMERCIALIZADORA INTEGRAL Y DE SERV. MIRSO, S. A. | 1 | 5,689.4 MXN | 6,566.3 % | 2,495.2 | 2010 - 2010 |
| DEFA, S.A. DE C.V. | 1 | 2,612.7 MXN | 17 % | 1,329.6 | 2009 - 2009 |
| DELOVAC, S. DE R.L. DE C.V. | 1 | 11,540.3 MXN | 34.5 % | 5,226.7 | 2012 - 2012 |
| DINORSA, S.A. DE C.V. | 1 | 184.6 MXN | 85.7 % | 85.7 | 2011 - 2011 |
| DISTRIBUIDORA A5 EXPRESS, SA DE CV | 1 | 13.4 MXN | 53.5 % | 5.89 | 2010 - 2010 |
| DISTRIBUIDORA ERCCO, S.A. DE C.V. | 1 | 261.1 MXN | 119.3 % | 114.5 | 2010 - 2010 |
| FARMACEUTICA AGO DEL PACIFICO, S.A. DE C.V. | 1 | 111,372.9 MXN | 103 % | 56,677.2 | 2009 - 2009 |
| FARMACIAS NACIONALES, S. A. DE C. V. | 1 | 19.1 MXN | 147.9 % | 8.87 | 2011 - 2011 |
| FARMAYOREO DEL GOLFO, S.A. DE C.V. | 1 | 0.956 MXN | 44.4 % | 0.444 | 2011 - 2011 |
| FERNOSIG, S. A. DE C. V. | 1 | 4,577.4 MXN | 4.17 % | 2,073.1 | 2012 - 2012 |
| GUZMAN CASTILLO MA. TERESA | 1 | 12,387.6 MXN | 1,870.1 % | 5,610.4 | 2012 - 2012 |
| JAFHARMA DE MEXICO, SA DE CV | 1 | 10,174.8 MXN | 103.6 % | 5,177.9 | 2009 - 2009 |
| MEDICA AVANZADA, S. A. DE C. V. | 1 | 253.7 MXN | 39.3 % | 117.8 | 2011 - 2011 |
| MEDICINAS SARO, S.A. DE C.V. | 1 | 140.7 MXN | 9.64 % | 61.7 | 2010 - 2010 |
| MONICA EUGENIA QUEVEDO CASTRO | 1 | 1,753.7 MXN | 8.7 % | 794.3 | 2012 - 2012 |
| Proveedor local no identificado (Compra Emergente) | 1 | 2,789.9 MXN | 163.1 % | 1,223.6 | 2010 - 2010 |
| PROVEEDORA OCCIDENTAL DE MEDICAMENTOS,S.A. DE C.V. | 1 | 29,312.2 MXN | 25.9 % | 12,855.6 | 2010 - 2010 |
| REPRESENTACIONES MEDICAS DEL NORTE, S.A. DE C.V. | 1 | 19,220.8 MXN | 64.9 % | 8,705.2 | 2012 - 2012 |
Date updated in QQW
3 de octubre de 2022
Source(s)
Part of the project
Organization responsible for the import